Transcription of Reference ID: 3366104 - ZEVALIN
{{id}} {{{paragraph}}}
Example: biology
Reference ID: 3366104 - ZEVALIN
HIGHLIGHTS OF PRESCRIBING information ---------------------DOSAGE FORMS AND STRENGTHS---------------------- These highlights do not include all the information needed to use mg per 2 mL in a single-use vial. (3). ZEVALIN safely and effectively. See full prescribing information for ZEVALIN . -------------------------------CONTRAIND ICATIONS------------------------------ None. ZEVALIN (ibritumomab tiuxetan). Injection for intravenous use -----------------------WARNINGS AND PRECAUTIONS------------------------ Initial Approval: 2002 Serious Infusion Reactions: Immediately discontinue rituximab and Y- 90 ZEVALIN . ( , ). WARNING: SERIOUS INFUSION REACTIONS, PROLONGED Prolonged and Severe Cytopenias: Do not administer ZEVALIN to patients AND SEVERE CYTOPENIAS, and SEVERE CUTANEOUS AND with 25% lymphoma marrow involvement or impaired bone marrow MUCOCUTANEOUS REACTIONS reserve.
full prescribing information warning: serious infusion reactions, prolonged and severe cytopenias, and severe cutaneous and mucocutaneous reactions
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: